The newly formed Advisory Committee on Immunization Practices has voted 5-2 to recommend Merck’s respiratory syncytial virus monoclonal antibody drug, clesrovimab, for infants younger than 8 months.

The votes in favor of Merck’s shot are a sigh of relief after Kennedy gutted the panel and tapped replacements, some of whom ...

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s ...

U.S. Health Secretary Robert F. Kennedy Jr.’s new vaccine advisers alarmed pediatricians Wednesday by announcing inquiries ...